GENE ONLINE|News &
Opinion
Blog

Cystic Fibrosis
Pfizer Partners with Renowned Life Sciences VC to Build Pipeline Projected to be Worth $7 Billion
2023-07-20
Vertex’s Orkambi Racks Up Another Approval For Cystic Fibrosis
2022-09-05
Why Cells Move Faster Through Mucus Than Blood
2022-07-28
First Successful Use of Phages for Treating Antibiotic-Resistant Lung Infection
2022-05-16
Tessera Therapeutics Partners with Cystic Fibrosis Foundation to Treat Life-Threatening Disease with Gene Writers
2021-11-05
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
FDA Approves 3 Cystic Fibrosis Drugs of Vertex for Patients with Rare Mutations
2020-12-24
Vertex Bags EU Approval for Cystic Fibrosis Treatment in Children Aged 6-11 Years
2020-11-29
Ionis’ Inhaled Antisense Medicine Could Signal Decline for Cystic Fibrosis Medical Devices
2020-10-15
Cystic Fibrosis: ZFN Mediated Gene Editing Results in Functional CFTR Correction
2020-05-13
An Outlook on the Evolution of Cystic Fibrosis Care
2020-05-13
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top